In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 mo.
Annals of internal medicine（2023）
摘要
Nissen SE, Lincoff MA, Brennan D, et al; CLEAR Outcomes Investigators. N Engl J Med. 2023;388:1353-1364. 36876740.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要